Raven biosciences ApS: Financial statements 2021
CVR: 39085127
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Raven biosciences ApS (CVR 39085127) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 5,956,861 and a net result of DKK 710,153 compared with DKK -255,472 the year before. That is an increase of 165.5% compared with the year before. The profit margin was 11.9%. Equity in the 2021 report amounted to DKK 1,015,093. The solvency ratio was 34%.
- Revenue
- DKK 5,956,861
- Gross Profit
- DKK 3,398,525
- Profit/Loss
- DKK 710,153
- Equity
- DKK 1,015,093
- Total Assets
- DKK 2,986,788
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 6M | 3.4M | 710K | 1M | - |
| 2020 | 2.2M | 2.1M | -255K | 413K | - |
| 2019 | 4.8M | 3.4M | 413K | 669K | - |
Official annual report
Find more companies like Raven biosciences ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Raven biosciences ApS has published its annual report for 2020. Revenue came to DKK 2,243,527, and the net result was DKK -255,472.
About Raven biosciences ApS
Raven biosciences ApS is a Danish company of the type Anpartsselskab based in Aarhus N, founded in 2017. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kenneth Graabek Johansen and Roald Forsberg. The company's owners include Kenneth Graabek Johansen, Roald Forsberg and KGJ Invest ApS. The company has 7 employees (2026). In 2025, the company reported revenue of DKK 6,977,057 and a net result of DKK 1,065,066 compared with DKK -925,200 the year before. Equity in the 2025 report amounted to DKK 2,861,815.